Zeyidan Jiapaer

Dr. Zeyidan Jiapaer

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ZJZeyidan Jiapaer
Zeyidan Jiapaer
CLChengyu Li Li
Chengyu Li Li
XYXinyu Yang
Xinyu Yang
LSLingfei Sun
Lingfei Sun
ECEmeli Chatterjee
Emeli Chatterjee
Guoping LiGuoping Li
Guoping Li
Cardiovascular diseases (CVDs) remain the world’s leading cause of death despite the best available healthcare and therapy. Emerging as a key mediator of intercellular and inter-organ communication in CVD pathogenesis, extracellular vesicles (EVs) are a heterogeneous group of membrane-enclosed nano-sized vesicles released by virtually all cells, of which their RNA cargo, especially non-coding RNAs (ncRNA), has been increasingly recognized as a promising diagnostic and therapeutic target. Recent evidence shows that ncRNAs, such as small ncRNAs, circular RNAs, and long ncRNAs, can be selectively sorted into EVs or other non-vesicular carriers and modulate various biological processes in recipient cells. In this review, we summarize recent advances in the literature regarding the origin, extracellular carrier, and functional mechanisms of extracellular ncRNAs with a focus on small ncRNAs, circular RNAs, and long ncRNAs. The pathophysiological roles of extracellular ncRNAs in various CVDs, including atherosclerosis, ischemic heart diseases, hypertension, cardiac hypertrophy, and heart failure, are extensively discussed. We also provide an update on recent developments and challenges in using extracellular ncRNAs as biomarkers or therapeutical targets in these CVDs.

7 October 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
ZJZeyidan Jiapaer
Zeyidan Jiapaer
LZLingying Zhang
Lingying Zhang
WMWanli Ma
Wanli Ma
HLHaoqiang Liu
Haoqiang Liu
CLChengyu Li
Chengyu Li
SSShuxuan Shao
Shuxuan Shao
Colorectal cancer is one of the most common malignancies causing the majority of cancer-related deaths. There is an urgent need to develop new anticancer modalities. Recently, efforts have been made to turn clinically approved drugs into anticancer agents in specific tumor microenvironments via NPs. Disulfiram (DSF) as an effective copper (Cu2+)-dependent anti-tumour drug, which has been more widely used in antitumor research. Here, we constructed a novel therapeutic nanoplatforms, DSF@CuS, by encapsulating DSF in hollow CuS NPs to enable in situ chemoselective activation of DSF and hyperthermal amplified chemotherapy. The anticancer effect of DSF was enhanced by the thermal energy generated under NIR irradiation through the intrinsic photothermal conversion of CuS. As a result, significant apoptosis was induced in vitro, and tumor elimination was achieved in vivo. Collectively, DSF@CuS combined with photothermal therapy can significantly promote the apoptosis of CT26 colorectal cancer cells both in vitro and in vivo, providing a potential theoretical agent for the treatment of colorectal cancer.

25 March 2025 in Translational Neurodegeneration
Verified
Journal Article
Open access
PDF file
WZWenchuan Zhang
Wenchuan Zhang
CHChenxuan Huang
Chenxuan Huang
HYHaiyang Yao
Haiyang Yao
SYShangzhi Yang
Shangzhi Yang
ZJZeyidan Jiapaer
Zeyidan Jiapaer
XWXianli Wang
Xianli Wang
Neurological disorders present considerable challenges in diagnosis and treatment due to their complex and diverse etiology. Retrotransposons are a type of mobile genetic element that are increasingly revealed to play a role in these diseases. This review provides a detailed overview of recent developments in the study of retrotransposons in neurodevelopment, neuroaging, and neurological diseases. Retrotransposons, including long interspersed nuclear elements-1, Alu, SINE-VNTR-Alu, and endogenous retrovirus, play important regulatory roles in the development and aging of the nervous system. They have also been implicated in the pathological processes of several neurological diseases, including Alzheimer's disease, X-linked dystonia-parkinsonism, amyotrophic lateral sclerosis, autism spectrum disorder, and schizophrenia. Retrotransposons provide a new perspective for understanding the molecular mechanisms underlying neurological diseases and provide insights into diagnostic and therapeutic strategies of these diseases.

24 April 2025 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
LZLingying Zhang
Lingying Zhang
CLChengyu Li
Chengyu Li
NZNa Zhu
Na Zhu
ECEmeli Chatterjee
Emeli Chatterjee
JCJie Chen
Jie Chen
ZJZeyidan Jiapaer
Zeyidan Jiapaer

29 November 2022 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
LZLingying Zhang
Lingying Zhang
CLChengyu Li
Chengyu Li
MZMarhaba·a Ziz
Marhaba·a Ziz
RZRongxin Zhu
Rongxin Zhu
ZJZeyidan Jiapaer
Zeyidan Jiapaer

27 February 2026 in Genes
Verified
Journal Article
Open access
PDF file
CLChengyu Li Li
Chengyu Li Li
ZJZeyidan Jiapaer
Zeyidan Jiapaer
YMYusupujiang Maimaiti
Yusupujiang Maimaiti
TWTing Wang
Ting Wang
XZXin Zhang
Xin Zhang
ZJZeyidan Jiapaer
Zeyidan Jiapaer
Background: Sirtuin 1 (Sirt1) is known to regulate stem cell differentiation and cardiomyocyte function, yet its specific role and mechanism in human embryonic stem cell (hESC) differentiation into cardiomyocytes remain unclear. This study aimed to elucidate the functional contribution and molecular pathway of Sirt1 in cardiomyogenesis. Methods: A Sirt1 knockout (Sirt1−/−) hESC line was generated using CRISPR-Cas9 technology. The expression of key differentiation markers was analyzed by RT-qPCR at days 6, 8, and 9. The underlying mechanism was investigated through integrated RNA-sequencing (RNA-seq) analysis and dual-luciferase reporter assays. Results: Sirt1 deletion significantly downregulated the expression of mesodermal (TBX6, KDR), cardiac precursor (NKX2.5, TBX5), and mature cardiomyocyte (cTNT, Hand2) markers. Mechanistically, a competing endogenous RNA (ceRNA) axis, LncRNA XR_951230.1/miR-3663-3p/SMYD1, was identified. Sirt1 knockout reduced XR_951230.1 expression, which consequently elevated miR-3663-3p activity and suppressed its target gene SMYD1. Conclusions: These findings indicate that Sirt1 is essential for promoting hESC differentiation into cardiomyocytes, potentially via the XR_951230.1/miR-3663-3p/SMYD1 pathway. This study provides new insights into the regulatory network of stem cell-based cardiomyogenesis and suggests potential targets for stem cell-based cardiac disease therapy.